Evropi Theodoratou

Professor of Cancer Epidemiology and Global Health

Biography

Background

Current roles

  • Professor of Cancer Epidemiology and Global Health, University of Edinburgh
  • Co-lead UNCOVER (Applied Evidence Synthesis)
  • Deputy PGR Director for the Usher Institute

Previous roles

  • Reader, University of Edinburgh
  • Senior Lecturer/ Chancellor’s Fellow, University of Edinburgh
  • Post-doctoral research fellow, University of Edinburgh
  • CRUK Population research post-doctoral fellow, University of Edinburgh

Qualifications

  • BSc in Biology, Aristotle University of Thessalonica, Greece
  • MSc in Medical Biology, University of Linkoping, Sweden
  • PhD in Cancer Epidemiology, University of Edinburgh, UK

Responsibilities & affiliations

  • Fellow by distinction of the Faculty of Public Health (2018)
  • Chief Scientist Office, Health Improvement, Protection and Services Research Committee
  • Cancer Research UK, Prevention and Population Research Committee
  • Affiliate scientist, Stanford University (USA), Stanford School of Medicine, METRICS (Meta-research Innovation Centre at Stanford)

Postgraduate teaching

Course co-Director of “Applied Epidemiology”, an elective for the University of Edinburgh’s Master of Public Health (MPH) online programme.

Professor Theodoratou currently supervises MPH students, MSc students, undergraduate students, PhD students and MRes students.

Open to PhD supervision enquiries?

Yes

Research summary

Professor Theodoratou’s primary research interest is in colorectal cancer epidemiology (see www.ed.ac.uk/cancer-centre/research/evropi-theodoratou for more information). This research focuses on projects in genetic, molecular and clinical epidemiology. 

Another active research area is the application of the phenome-wide association study methodology (PheWAS) to investigate the associations between certain genetic variations or biomarker levels and multiple clinical outcomes.

Professor Theodoratou is also interested in developing and applying new research methods in relation to empirical research and evidence-based medicine. She co-leads UNCOVER, a network of population health researchers and information specialists who are committed to responding quickly to requests from policymakers for evidence reviews in relation to the COVID-19 pandemic. See www.ed.ac.uk/usher/uncover for more information.

This article was published on